Ar 5 Awst, cyhoeddodd y Cyd-bwyllgor ar Imiwneiddio a Brechu ddatganiadau sy’n egluro ei gyngor ar newidiadau i’r rhaglenni feirws papiloma dynol (HPV) ac imiwneiddio plant. Mae’r Cyd-bwyllgor wedi argymell y canlynol:symud at roi un dos o’r brechlyn HPV i grwpiau penodol, anewid yr amserlen imiwneiddio arferol ar gyfer babanod gan fod y ddarpariaeth o’r brechlyn Menitorix© (Hib/MenC) yn dod i ben.
On 5 August the Joint Committee on Vaccination and Immunisation (JCVI), published statements setting out its advice on changes to the human papillomavirus (HPV) and childhood immunisation programmes. The Committee has recommended:a move to one dose of the HPV vaccination for certain groups and,a change to the routine infant schedule due to the discontinuation of the Menitorix© (Hib/MenC) vaccine.